122 related articles for article (PubMed ID: 31277556)
21. Plasma thrombopoietin concentrations in response to platelet transfusion therapy.
Möller P; Andersson PO; Andersson AC; Wadenvik H
Acta Haematol; 2000; 102(3):131-4. PubMed ID: 10692675
[TBL] [Abstract][Full Text] [Related]
22. Pathogen-reduced platelets for the prevention of bleeding.
Butler C; Doree C; Estcourt LJ; Trivella M; Hopewell S; Brunskill SJ; Stanworth S; Murphy MF
Cochrane Database Syst Rev; 2013 Mar; (3):CD009072. PubMed ID: 23543569
[TBL] [Abstract][Full Text] [Related]
23. The impact of platelet additive solution apheresis platelets on allergic transfusion reactions and corrected count increment (CME).
Tobian AA; Fuller AK; Uglik K; Tisch DJ; Borge PD; Benjamin RJ; Ness PM; King KE
Transfusion; 2014 Jun; 54(6):1523-9; quiz 1522. PubMed ID: 24251374
[TBL] [Abstract][Full Text] [Related]
24. [The efficacy and safety of autologous cryopreserved platelet transfusion in management of thrombocytopenia after chemotherapy in hematological malignancy].
Liu GQ; Ding HF; Lu XJ; Xu M; Xing J; Zhao X; Han F; Shang YH
Zhonghua Nei Ke Za Zhi; 2012 Mar; 51(3):188-91. PubMed ID: 22781890
[TBL] [Abstract][Full Text] [Related]
25. Clinical and laboratory correlates of platelet alloimmunization and refractoriness in the PLADO trial.
Hess JR; Trachtenberg FL; Assmann SF; Triulzi DJ; Kaufman RM; Strauss RG; Granger S; Slichter SJ
Vox Sang; 2016 Oct; 111(3):281-291. PubMed ID: 27185561
[TBL] [Abstract][Full Text] [Related]
26. Patient and product factors affecting platelet transfusion results.
Heim D; Passweg J; Gregor M; Buser A; Theocharides A; Arber C; Meyer-Monard S; Halter J; Tichelli A; Gratwohl A
Transfusion; 2008 Apr; 48(4):681-7. PubMed ID: 18208413
[TBL] [Abstract][Full Text] [Related]
27. Coagulopathy, catecholamines, and biomarkers of endothelial damage in experimental human endotoxemia and in patients with severe sepsis: a prospective study.
Ostrowski SR; Berg RM; Windeløv NA; Meyer MA; Plovsing RR; Møller K; Johansson PI
J Crit Care; 2013 Oct; 28(5):586-96. PubMed ID: 23731819
[TBL] [Abstract][Full Text] [Related]
28. Biomarkers of Complement and Platelet Activation are not correlated with the One or Twenty-Four Hours Corrected Count Increments in Prophylactically Platelet Transfused Hematological Patients: a Prospective Cohort Study.
Åkesson A; Ljungkvist M; Martin M; Blom AM; Klintman J; Schött U; Zetterberg E; Kander T
Platelets; 2022 Apr; 33(3):350-359. PubMed ID: 34210243
[TBL] [Abstract][Full Text] [Related]
29. Corrected count increment and percent platelet recovery as measures of posttransfusion platelet response: problems and a solution.
Davis KB; Slichter SJ; Corash L
Transfusion; 1999 Jun; 39(6):586-92. PubMed ID: 10378838
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic efficacy of platelet components treated with amotosalen and ultraviolet A pathogen inactivation method: results of a meta-analysis of randomized controlled trials.
Cid J; Escolar G; Lozano M
Vox Sang; 2012 Nov; 103(4):322-30. PubMed ID: 22563850
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of prophylactic transfusions using single donor apheresis platelets versus pooled platelet concentrates in AML/MDS patients receiving allogeneic hematopoietic stem cell transplantation.
Gurkan E; Patah PA; Saliba RM; Ramos CA; Anderson BS; Champlin R; de Lima M; Lichtiger B
Bone Marrow Transplant; 2007 Sep; 40(5):461-4. PubMed ID: 17589530
[TBL] [Abstract][Full Text] [Related]
32. [Analysis of Factors Influencing Posttransfusion Effectiveness in 26045 Cases of Platelet Transfusion].
Chen LF; Pan JC; Feng Q; Luo YY; Yu Y; Zhuang Y; Li H; Feng YN; Wang DQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Aug; 23(4):1081-6. PubMed ID: 26314450
[TBL] [Abstract][Full Text] [Related]
33. Platelet transfusions.
Stroncek DF; Rebulla P
Lancet; 2007 Aug; 370(9585):427-38. PubMed ID: 17679020
[TBL] [Abstract][Full Text] [Related]
34. A multi-centre study of therapeutic efficacy and safety of platelet components treated with amotosalen and ultraviolet A pathogen inactivation stored for 6 or 7 d prior to transfusion.
Lozano M; Knutson F; Tardivel R; Cid J; Maymó RM; Löf H; Roddie H; Pelly J; Docherty A; Sherman C; Lin L; Propst M; Corash L; Prowse C
Br J Haematol; 2011 May; 153(3):393-401. PubMed ID: 21418180
[TBL] [Abstract][Full Text] [Related]
35. The assessment of platelet function by thromboelastometry as a point-of-care test to guide Intercept-treated platelet support in hemato-oncological patients and hematopoietic stem cell transplantation recipients.
Leitner GC; Ho M; Tolios A; Hopfinger G; Rabitsch W; Wohlfarth P
Transfusion; 2020 Jul; 60(7):1391-1399. PubMed ID: 32319678
[TBL] [Abstract][Full Text] [Related]
36. A randomized study of buffy coat platelets in platelet additive solution stored 1-5 versus 6-7 days prior to prophylactic transfusion of allogeneic haematopoietic progenitor cell transplant recipients.
Diedrich B; Ringdén O; Watz E; Shanwell A
Vox Sang; 2009 Oct; 97(3):254-9. PubMed ID: 19508669
[TBL] [Abstract][Full Text] [Related]
37. "Endothelial Dysfunction in Resuscitated Cardiac Arrest (ENDO-RCA): Safety and efficacy of low-dose Iloprost, a prostacyclin analogue, in addition to standard therapy, as compared to standard therapy alone, in post-cardiac-arrest-syndrome patients.".
Meyer ASP; Johansson PI; Kjaergaard J; Frydland M; Meyer MAS; Henriksen HH; Thomsen JH; Wiberg SC; Hassager C; Ostrowski SR
Am Heart J; 2020 Jan; 219():9-20. PubMed ID: 31710844
[TBL] [Abstract][Full Text] [Related]
38. In-vivo evaluation of random donor platelet concentrates from pooled buffy coats.
Klüter H; Dörges L; Maass E; Wagner T; Bartels H; Kirchner H
Ann Hematol; 1996 Aug; 73(2):85-9. PubMed ID: 8774617
[TBL] [Abstract][Full Text] [Related]
39. The association between haemorrhage and markers of endothelial insufficiency and inflammation in patients with hypoproliferative thrombocytopenia: a cohort study.
Ypma PF; van Geloven N; Kerkhoffs JLH; Te Boekhorst P; Zwaginga JJ; Beckers EAM; Brand A; van der Meer PF; Eikenboom JCJ
Br J Haematol; 2020 Apr; 189(1):171-181. PubMed ID: 31730713
[TBL] [Abstract][Full Text] [Related]
40. Transfusion of ABO non-identical platelets does not influence the clinical outcome of patients undergoing autologous haematopoietic stem cell transplantation.
Solves P; Carpio N; Balaguer A; Romero S; Iacoboni G; Gómez I; Lorenzo I; Moscardó F; Sanz J; Lopez F; Martin G; Jarque I; Montesinos P; De La Rubia J; Sanz G; Sanz MA
Blood Transfus; 2015 Jul; 13(3):411-6. PubMed ID: 25761311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
